Cargando…

Antimicrobial use in Canadian acute-care hospitals: Findings from three national point-prevalence surveys between 2002 and 2017

OBJECTIVES: The Canadian Nosocomial Infection Surveillance Program conducted point-prevalence surveys in acute-care hospitals in 2002, 2009, and 2017 to identify trends in antimicrobial use. METHODS: Eligible inpatients were identified from a 24-hour period in February of each survey year. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jennifer J., Rudnick, Wallis, Mitchell, Robyn, Brooks, James, Bush, Kathryn, Conly, John, Ellison, Jennifer, Frenette, Charles, Johnston, Lynn, Lavallée, Christian, McGeer, Allison, Mertz, Dominik, Pelude, Linda, Science, Michelle, Simor, Andrew, Smith, Stephanie, Stagg, Paula, Suh, Kathryn N., Thampi, Nisha, Thirion, Daniel J.G., Vayalumkal, Joseph, Wong, Alice, Taylor, Geoffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672830/ https://www.ncbi.nlm.nih.gov/pubmed/35249564 http://dx.doi.org/10.1017/ice.2021.519

Ejemplares similares

Patients in hospital with laboratory-confirmed COVID-19 in a network of Canadian acute care hospitals, Mar. 1 to Aug. 31, 2020: a descriptive analysis
por: Mitchell, Robyn, et al.
Publicado: (2021)

Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022
por: Mitchell, Robyn, et al.
Publicado: (2023)

Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016
por: Rudnick, Wallis, et al.
Publicado: (2020)

The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals
por: Frenette, Charles, et al.
Publicado: (2020)

Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018
por: Rudnick, Wallis, et al.
Publicado: (2023)

481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022
por: Lee, Diane, et al.
Publicado: (2023)

Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
por: Garcia-Jeldes, Hector Felipe, et al.
Publicado: (2020)

Epidemiology of central-line–associated bloodstream infection mortality in Canadian NICUs before and after 2017
por: Spagnuolo, Maria, et al.
Publicado: (2023)

In Vitro Activity of New Cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008–2011
por: Green, Karen, et al.
Publicado: (2014)

Epidemiological features of influenza in Canadian adult intensive care unit patients
por: TAYLOR, G., et al.
Publicado: (2016)

The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey
por: German, Greg J., et al.
Publicado: (2021)

1426. Impact of Routine Pediatric PCV13 on the Incidence and Severity of Invasive Pneumococcal Disease in Adults in Ontario, Canada
por: Nayani, Sarah, et al.
Publicado: (2018)

2401. Risk Factors for Antimicrobial Resistance in Invasive Pneumococcal disease (IPD) in Toronto, Canada, 2012–2017
por: Fear, Thomas, et al.
Publicado: (2018)

Preventing the introduction of SARS-CoV-2 into school settings
por: Thampi, Nisha, et al.
Publicado: (2021)

Comment empêcher le SRAS-CoV-2 d’entrer dans les écoles
por: Thampi, Nisha, et al.
Publicado: (2021)

Prevalence of antimicrobial use in a network of Canadian hospitals in 2002 and 2009
por: Taylor, Geoffrey, et al.
Publicado: (2015)

462. Prospective Surveillance of Invasive Group A Streptococcal Infections in Toronto, Ontario, Canada: 1992–2017
por: Kandel, Christopher, et al.
Publicado: (2019)

2716. Persistence of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Serotypes in Invasive Pneumococcal Disease in Adults in Southern Ontario Canada Despite Routine Pediatric Vaccination
por: McGeer, Allison, et al.
Publicado: (2019)

Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015–2019
por: Du, Tim, et al.
Publicado: (2022)

Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic
por: Taylor, Geoffrey, et al.
Publicado: (2014)

2166. Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) Hospitals, 2018
por: Jeldes, Felipe Garcia, et al.
Publicado: (2018)

School-Based Mandatory Masking Policies and Absenteeism in Ottawa, Canada, in 2022
por: Thampi, Nisha, et al.
Publicado: (2023)

Antimicrobial use over a four-year period using days of therapy measurement at a Canadian pediatric acute care hospital
por: Dalton, Bruce R, et al.
Publicado: (2015)

Methicillin-resistant Staphylococcus aureus in Horses and Horse Personnel, 2000–2002
por: Weese, J.S., et al.
Publicado: (2005)

Cerebrospinal fluid shunt–associated surgical site infection with three-month versus twelve-month surveillance periods in Canadian hospitals
por: Choi, Kelly B., et al.
Publicado: (2023)

Laboratory-confirmed pandemic H1N1 influenca in hospitalized adults – findings from the Canadian Nosocomial Infection Surveillance Program (CNISP), 2009-10
por: Taylor, G, et al.
Publicado: (2011)

Changing Epidemiology of Invasive Pneumococcal Disease due to Conjugate Vaccine Serotypes in Toronto, Canada After Introduction of a Routine Pediatric PCV13 Program
por: Mcgeer, Allison, et al.
Publicado: (2017)

Risk of transmission of respiratory viruses during aerosol-generating medical procedures (AGMPs) revisited in the COVID-19 pandemic: a systematic review
por: Leal, Jenine, et al.
Publicado: (2022)

Impact of COVID-19 on healthcare-associated infections in Canadian acute-care hospitals: Interrupted time series (2018–2021)
por: Silva, Anada, et al.
Publicado: (2023)

Optimizing antibiotics in residents of nursing homes: protocol of a randomized trial
por: Loeb, Mark, et al.
Publicado: (2002)

Epidemiology and Outcome of Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals
por: Tadros, Manal, et al.
Publicado: (2013)

1143. Measuring Up! Benchmarking Antimicrobial Use in Canadian Children’s Hospitals
por: Blackburn, Julie, et al.
Publicado: (2019)

Designs 2002: further computational and constructive design theory
por: Wallis, W
Publicado: (2003)

Hypervirulent Clostridium difficile Strains in Hospitalized Patients, Canada
por: Mulvey, Michael R., et al.
Publicado: (2010)

270. Prevalence and Impact of β-Lactam Allergies at a Canadian Pediatric Center
por: Wong, Jacqueline, et al.
Publicado: (2018)

1211. Incidence of All-Cause Community-Acquired Pneumonia in Ontario and British Columbia, Canada, 2002-2018; a Canadian Immunization Research Network (CIRN) study
por: Nasreen, Sharifa, et al.
Publicado: (2021)

History of Innate Immunity in Neurodegenerative Disorders
por: McGeer, Patrick L., et al.
Publicado: (2011)

Microsoft Word 2002 : introducción
por: Duffy, Jennifer A.
Publicado: (2002)

Determination of SARS-CoV-2 Contamination in a Neonatal Intensive Care Unit (NICU) Environment Using Droplet Digital PCR (ddPCR)
por: Vayalumkal, J., et al.
Publicado: (2022)

Nursing Home Residents and Enterobacteriaceae Resistant to Third-Generation Cephalosporins
por: Sandoval, Carolyn, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_3v4d8kokbcafohrtjiorhggf39